Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Note Payable (Tables)

12 Months Ended

Nov. 30, 2020

As of November 30, 2020, and November 30, 2019, the note payable obligation was as follows:

	November 30, 2020			November 30, 2019
Note payable	$	6,008,433		$	9,108,433
Unamortized debt issuance costs		(67,219	)		(152,281	)
Net note payable	$	5,941,214		$	8,956,152
Current portion of note payable	$	3,100,000		$	3,100,000
Long-term note payable, net of debt issuance costs		2,841,214			5,856,152
Total	$	5,941,214		$	8,956,152

Future principal payments under the note payable obligation are as follows:

Interest expense on the note payable for the years ended November 30, 2020 and November 30, 2019 was as follows:

	November 30, 2020		November 30, 2019
Interest expense on notes payable	$	310,364	$	646,744
Debt issuance costs		85,062		112,642
Total interest expense	$	395,426	$	759,386